Literature DB >> 2500449

Regulation of levels of IL-1 mRNA in human fibroblasts.

K Yamato1, Z el-Hajjaoui, H P Koeffler.   

Abstract

Interleukin-1 (IL-1) has a crucial role in host defenses, inflammatory processes, and tissue homeostasis. A wide variety of cells produce this protein in response to a number of extracellular stimuli including microorganisms, antigenic stimuli, and products from other cells. Regulation of IL-1 production at the molecular level is poorly understood. We studied expression, intracellular signals, and posttranscriptional regulation of IL-1 mRNA in human mesenchymal cells by using Northern blot analysis. Tumor necrosis factor alpha (TNF alpha) and activators of protein kinase C including 12-O-tetradecanoylphorbol-13-acetate (TPA) and teleocidin induced the accumulation of IL-1 beta mRNA in human fibroblasts (WI-38). Effect of TNF alpha was not blocked by inhibitors of either protein synthesis (cycloheximide) or protein kinase C activity. Accumulation of IL-1 beta mRNA was also increased by a calcium ionophore (A23187) and an inhibitor of the Na+/K+ pump (ouabain); both compounds are known to increase cytoplasmic levels of Ca++. Stability of IL-1 beta mRNA in fibroblasts exposed to TPA was more than fourfold greater than after fibroblasts were exposed to either TNF alpha or cycloheximide. This suggests that posttranscriptional stabilization of IL-1 beta mRNA is a major mechanism leading to accumulation of IL-1 beta mRNA after activation of PKC in fibroblasts. Fibroblasts did not express IL-1 alpha mRNA after exposure to stimuli which induced the accumulation of IL-1 beta mRNA. In summary, several different pathways regulate levels of IL-1 beta mRNA in human mesenchymal cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500449     DOI: 10.1002/jcp.1041390322

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.

Authors:  Y Kawaguchi; M Hara; T M Wright
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  A phorbol ester-regulated ribonuclease system controlling transforming growth factor beta 1 gene expression in hematopoietic cells.

Authors:  R E Wager; R K Assoian
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

3.  Posttranscriptional regulation of interferon mRNA levels in peritoneal macrophages.

Authors:  S Gessani; P Di Marzio; P Rizza; F Belardelli; C Baglioni
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

4.  Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts.

Authors:  S Kumar; A J Millis; C Baglioni
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

5.  Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells.

Authors:  P Conti; C Feliciani; R C Barbacane; M R Panara; M Reale; F C Placido; D N Sauder; R A Dempsey; P Amerio
Journal:  Immunology       Date:  1992-10       Impact factor: 7.397

6.  A CRE/ATF-like site in the upstream regulatory sequence of the human interleukin 1 beta gene is necessary for induction in U937 and THP-1 monocytic cell lines.

Authors:  J G Gray; G Chandra; W C Clay; S W Stinnett; S A Haneline; J J Lorenz; I R Patel; G B Wisely; P J Furdon; J D Taylor
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

7.  Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.

Authors:  M Maruyama; J G Hay; K Yoshimura; C S Chu; R G Crystal
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

8.  Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis.

Authors:  Periklis Vounotrypidis; Georgios Kouklakis; Konstantinos Anagnostopoulos; Petros Zezos; Alexandros Polychronidis; Efstratios Maltezos; Eleni Efremidou; Michael Pitiakoudis; Nikolaos Lyratzopoulos
Journal:  Auto Immun Highlights       Date:  2013-02-22

9.  Inflammasome inhibition blocks cardiac glycoside cell toxicity.

Authors:  Doris L LaRock; Jenna S Sands; Ethan Ettouati; Marine Richard; Paul J Bushway; Eric D Adler; Victor Nizet; Christopher N LaRock
Journal:  J Biol Chem       Date:  2019-07-12       Impact factor: 5.157

10.  Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils.

Authors:  T Khair-El-Din; S C Sicher; M A Vazquez; G W Chung; K A Stallworth; K Kitamura; R T Miller; C Y Lu
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.